Management of the Ocular Surface With Preservative-Free Lubricants in Patients With Dry Eye
NCT06162442 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 132
Last updated 2023-12-08
Summary
Observational and prospective cohort study that seek to evaluate the epidemiological characteristics and changes in the ocular surface of patients diagnosed with dry eye disease who are treated with preservative-free lubricating drops.
Conditions
Interventions
- DRUG
-
Preservative-free sterile ophthalmic solution, with 0.3% propylene glycol and 0.4% polyethylene glycol (400)
The procedures during the study consist of ophthalmological activities and attention to the participating subject with a diagnosis of DED and who starts using a specified ocular lubricant, free of preservatives. The ophthalmologist will notify the subject of the "wash out", which will consist of suspending the usual treatment medication for 7 days, to then start with the lubricant Glicolub Ultra®, with a dosage of 1 drop every 6 hours in both eyes. Self-assessment questionnaires will be delivered for their respective completion. An assessment will be made by the comprehensive ophthalmologist in all clinical tests for dry eye with a mild to moderate diagnosis, under compliance with the TOSF DEWS II criteria and study inclusion criteria.
Sponsors & Collaborators
-
Tecnoquimicas
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-03-15
- Primary Completion
- 2023-12-15
- Completion
- 2024-04-15
Countries
- Colombia
Study Locations
More Related Trials
-
A Clinical Evaluation Pilot Study of the Efficacy of Blink® Tears Lubricant Eye Drops for the Relief of Dry Eye Symptoms Following Implantation of Tecnis® Multifocal Introcular Lens
NCT01061268 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Tolerability of Artificial Tears in Dry Eye Subjects
NCT00932477 ·Status: COMPLETED ·Phase: NA
-
Quality of Life and Visual Acuity of Visglyc Eye Drops on Dry Eye Patients
NCT04063644 ·Status: COMPLETED ·Phase: NA
-
Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study
NCT04884217 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of the Chronic Application of Tear Formulations
NCT01384851 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Acceptability of Two Lubricant Eye Drops
NCT00756678 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT02242032 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of TL-925 as a Treatment for Dry Eye Disease
NCT05745064 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease
NCT04030962 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Randomized, Double Masked, Clinical Study of Subjects With Dry Eye Syndrome
NCT03162783 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Efficacy Study of Refresh Optive® Gel Drops in Patients With Dry Eye Disease
NCT02280473 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease
NCT01294384 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease
NCT01664949 ·Status: COMPLETED ·Phase: PHASE3
-
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
NCT01900249 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms
NCT00938704 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops
NCT05660681 ·Status: COMPLETED ·Phase: NA
-
A Safety and Efficacy Study of 2 Dosing Regimens of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution Compared With Vehicle in Patients With Dry Eye Disease.
NCT06244316 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye Syndrome
NCT01163643 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers
NCT01339936 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Objective Evaluation of Ocular Surface Lubricants in Two Environments
NCT01375582 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Disease
NCT05119920 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye Disease
NCT06225973 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Phase 2, Multi-center, Randomized, Double- Masked and Placebo-Controlled Study of YP-P10 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (ICECAP 1)
NCT05467293 ·Status: COMPLETED ·Phase: PHASE2
-
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear vs. Systane for Dry Eye Signs, Symptoms & Refractive Regression Associated With Myopic Laser in Situ Keratomilieusis (LASIK).
NCT00620893 ·Status: COMPLETED ·Phase: PHASE4
-
Dry Eye Treatment With Artificial Tears
NCT02420834 ·Status: COMPLETED ·Phase: NA